Positive data from a phase 2 clinical trial has proven the general mechanism of action of SK channel inhibition for treatment of atrial fibrillation (AF), an abnormal heart rhythm.
Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).
Oversubscribed, series B financing for Noema Pharma’s clinical stage assets has been successfully closed raising $112 million from new and existing investors.
After completing the acquisition of Aveo, the Korean chemical company wants its subsidiary to become a global leader in the therapeutic area within five years.
Poolbeg Pharma plc has been granted a patent by the US Patent and Trademark Office (USPTO) for ways of treating hypercytokinaemia using a small molecule immunomodulator.
Small molecule drug, Niraparib combined with abiraterone acetate (AA) and prednisone (P) significantly reduces the risk of disease progression, or death, in patients with a type of prostate cancer, a consultant in Spain has said.
Two men have been jailed and another handed a suspended sentence, for selling more than three million doses of prescription-only and unlicensed medicines, including controlled medicines.
Charité – Universitätsmedizin Berlin, one of Europe’s largest university hospitals is collaborating with UK-based Exscientia to make use of an artificial intelligence-driven precision medicine platform in haematological cancers.
When the pandemic broke, the whole world was thrown onto a steep learning curve. Everyone had to find new ways to adapt in their day to day lives as well as their working lives. There was no exception with clinical trials, with patients unable to attend...
Patient recruitment and retention is an ongoing issue for everyone working in the clinical trials field. Over recent weeks, OSP has interviewed or spoken to a number of companies about their solutions.
The two partners will pool capabilities to provide an expanded service to their clients, which will see Koneksa provide its digital biomarkers tools and SSI Strategy its expertise in drug development.
UC San Francisco will conduct a six-month clinical trial on hypertrophic cardiomyopathy, which will rely on feedback from Vivalink’s biometric data platform.
Our world is getting greener – or at least trying to with more people turning to electric vehicles, buying local seasonal fruit and vegetables, cafes and restaurants adopting paper straws and a growth in sales of eco-friendly home products, to name a...
In the first of a two-part interview with Medable’s chief growth officer, Sanskriti Thakur, we will learn about why she thinks the world of medicine is letting women down, what the future holds and how everyone should be paying more attention.
A clinical trial travel solution that can remove administrative burdens for research sites and eliminate logistical and financial barriers for participants has significantly expanded.
Mutation in the progranulin (GRN) gene is just one of several hereditary factors that can cause frontotemporal dementia, a rare and rapidly progressive neurodegenerative disease.
A clinic dedicated to providing care and services to undeserved and uninsured individuals with Duchenne and Becker muscular dystrophy opened its doors on Friday (March 3).
A licensing agreement has been signed that will give Spanish pharma company, Ferrer, worldwide rights to a treatment for progressive supranuclear palsy (PSP).
Year on year, the SCOPE summit brings thousands of people working in the pharma field together and the last one attracted more than 2,300 leaders in clinical operations and research.
The two companies announce a business combination via a proposed all share merger transaction, effectively combining the pipelines and workforce of the two biotechs.
The company is using a ‘lab-in-the-loop’ process to advance the drug discovery process, and stated that opening a new lab space represents a step forward on its path to ‘transform drug discovery’.
With several reports into the UK clinical trial landscape finding serious cause for concern, the government orders a review to “resolve key challenges” facing the sector.
Kemiex has secured equity investments from the strategic investment arm of CME Group, CME Ventures, the global data and analytics company DTN, as well as the family office Wille Finance.
Children in Europe living with HIV are on course to receive a once-daily treatment after EU marketing authorisation (EMA) was given to ViiV Healthcare’s Triumeq PD.
Software that can enhance stroke patient outcomes by decreasing detection time and reducing disabilities is the first CE marked device that can help find large vessel occlusions (LVOs).
A survey conducted to understand whether supply issues over amoxicillin have persisted in the US found that an overwhelming majority of pharmacists are still struggling to source the commonly-used antibiotic.
The Dutch company Pharming Group N.V. has switched its rare disease drug leniolisib from an accelerated assessment to a regular review with the European Medicines Agency (EMA).
The US Food and Drug Administration (FDA) has accepted Merck’s Prevymis (letermovir) for prophylaxis of cytomegalovirus (CMV) disease in kidney transplant patients for priority review.
The clinical stage biopharmaceutical company will use its RADR artificial intelligence (AI) and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development.
The partners announce that they will combine to use artificial intelligence to improve the identification and enrolment of patients for clinical trials.
